Anuh Pharma Limited has informed the Exchange regarding allotment of securities pursuant to Bonus at its meeting held on 0 ,
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.9 pts less than Nifty Microcap 250 and 2.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Anuh Pharma Limited has allotted 5,01,12,000 fully paid-up bonus equity shares of face value ₹5 each to its shareholders. The bonus shares were issued in a 1:1 ratio, meaning one bonus share for every one existing share held as on the record date of 15th July 2025. As a result, the company's paid-up equity share capital has doubled from ₹25.06 crore (5,01,12,000 shares) to ₹50.11 crore (10,02,24,000 shares). The new bonus shares will carry the same rights as existing shares, including eligibility for future dividends. The allotment was approved by the Board via a circular resolution passed on 16th July 2025.
This is a positive development for existing shareholders as their share count doubles without any additional cost, though the share price typically adjusts downward proportionally on the ex-bonus date, keeping overall holding value largely unchanged. The move rewards long-term shareholders and may improve liquidity by increasing the number of outstanding shares.